Breast Cancer Patient Equity Act
- Sponsor
- Rep. Chu, Judy [D-CA-28]
- Committees
- Ways and Means Committee (primary)
- Last action
- Oct 29, 2026
Bottom line
The bill expands Medicare coverage to include custom fabricated breast prostheses, aiming to provide more equitable access and patient choice for post-mastectomy care.
What it actually does
This bill amends the Social Security Act to mandate Medicare coverage for custom fabricated breast prostheses following a mastectomy, including their replacement. It also includes a conforming amendment to prevent Medicare from denying claims for these prostheses on the grounds of not being 'medically necessary,' addressing a current practice cited in the bill's findings.
Proponents argue
Supporters argue that this bill addresses a significant gap in Medicare coverage, promoting health equity by ensuring all women, especially older and minority women who are disproportionately affected, have access to a viable and often preferred alternative to surgical breast reconstruction. They contend that providing this option respects patient choice and may even be more cost-effective than surgical alternatives, without increasing the incidence of mastectomies.
Opponents contend
Critics of expanding Medicare benefits, or those who previously deemed these prostheses 'not medically necessary,' might argue that this bill could increase overall Medicare expenditures. They might also contend that existing coverage for standard prostheses or surgical reconstruction is sufficient, or that the medical necessity of custom fabricated prostheses has not been adequately established to warrant a new coverage mandate.
The bill is very short and clear, making it highly accessible for readers to understand its core purpose and provisions quickly.
Section 2(a) and 2(b)
Medicare Coverage for Custom Fabricated Breast Prostheses
This provision amends Section 1861(s)(8) of the Social Security Act to include custom fabricated breast prostheses, and their replacements, as items and services covered by Medicare following a mastectomy. Additionally, a conforming amendment to Section 1862(a)(7) ensures that Medicare cannot deny claims for these prostheses on the basis that they are 'not medically necessary,' thereby removing a significant barrier to coverage.
Supporters argue
Proponents argue this provision is crucial for health equity, as it provides a viable and often preferred alternative to surgical reconstruction, especially for patients who cannot or choose not to undergo surgery. They highlight that Medicare currently covers more costly surgical options but denies custom prostheses, creating an inequitable system that this bill rectifies by recognizing custom prostheses as a valid and necessary treatment.
Critics contend
Opponents, or those aligned with Medicare's current denial policy, might argue that this expansion of coverage could lead to increased federal spending without clear evidence that custom prostheses are medically superior or more cost-effective than existing options. They might also raise concerns about the precedent set by overriding a 'not medically necessary' determination for a specific device.
Tradeoffs
The provision balances the desire for expanded patient choice and health equity in post-mastectomy care against potential increases in Medicare program costs. It also addresses the tension between current Medicare policy, which deems these prostheses 'not medically necessary,' and the patient advocacy for their inclusion as a covered benefit.
This section makes a conforming amendment to Section 1862(a)(7) of the Social Security Act, which lists items and services that are generally excluded from Medicare coverage if they are 'not reasonable and necessary for the diagnosis or treatment of illness or injury.' The amendment explicitly exempts the newly covered custom fabricated breast prostheses from this 'not medically necessary' exclusion.
Section 2(b)
Why it matters:This is standard legislative practice to ensure that new provisions integrate correctly and effectively with existing statutes. Without this conforming amendment, the new coverage mandated in Section 2(a) could still be undermined by Medicare's ability to deny claims based on medical necessity.
Case for: The case for this amendment is that it ensures the primary intent of the bill—to provide Medicare coverage for custom fabricated breast prostheses—is fully realized. It prevents Medicare from continuing its current practice of denying claims for these prostheses as 'not medically necessary,' thereby making the new coverage truly effective for beneficiaries.
Case against: While there isn't a direct case against a conforming amendment itself, critics of the overall bill might view this as removing a mechanism for cost control or medical review. They might argue that the 'not medically necessary' clause serves an important function in preventing unnecessary expenditures, and its removal for this specific item could set a problematic precedent.
Estimated impact: This amendment ensures the full financial and patient impact of the primary coverage provision takes effect, as it removes the legal basis for Medicare to deny claims for custom fabricated breast prostheses on medical necessity grounds.